This item is not eligible for Amazon Prime, but millions of other items are. Join
Amazon Prime today. Already a member?
Sign in.
Product Description
Book Description
Incorporates the most recent innovations and experimental therapies to create an even more comprehensive source of information on all aspects of this problematic disease. Features new information concerning bioengineering and psoriasis, topical retinoids, FK 506, photodynamic therapy, anti-thyroid thioureylene, ascomycin derivatives, BCX 343 inhibitors, PH5T inhibitors, DAP-389 therapy, and more.
Synopsis
Broadening the topics that earned the Second Edition a reputation as the premier reference of its kind, "Psoriasis, Third Edition", incorporates the most recent innovations and experimental therapies to create an even more comprehensive source of information on all aspects of this problematic disease. It features new information concerning bioengineering and psoriasis; topical retinoids FK 506 photodynamic therapy; ascomycin derivatives PH5T inhibitors DAP-389 therapy and more! Completely updated with the latest developments in areas such as neuropeptides, acitretin, and patient involvement, this valuable monograph pools the insights of over 120 distinguished dermatologists on all aspects of psoriasis, detailing genetics, etiology, biology, pathophysiology, clinical manifestations, pharmacology and therapeutics. This book provides a wealth of information for practicing physicians treating patients in a clinical setting - including dermatologists, internists, rheumatologists, allergists, family physicians, pediatricians, immunologists, biochemists, radiologists, and graduate and medical students in these disciplines.
